Specialty Crop Research Initiative Request for Pre-applications

Funding Opportunity ID: 289172 Opportunity Number: USDA-NIFA-SCRI-006064 Opportunity Title: Specialty Crop Research Initiative Request for Pre-applicationsOpportunity Category: MandatoryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: AgricultureCategory Explanation: CFDA Number(s): 10.309Eligible Applicants: Others (see text field entitled "Additional Information on Eligibility" for clarification)Additional Information on Eligibility: Pre-Applications may only be submitted by Federal agencies, national laboratories, colleges and universities, research institutions and organizations, private organizations or corporations, State Agricultural Experiment Stations, Cooperative Extension Services, individuals, or groups consisting of two or more of these entities.Agency Code: USDA-NIFAAgency Name: Department of AgricultureNational Institute of Food and AgriculturePosted Date: Sep 27, 2016Close Date: Nov 15, 2016Last Updated Date: Sep 27, 2016Award Ceiling: Award Floor: Estimated Total Program Funding: $48,128,978Expected Number of Awards: Description: The purpose of the SCRI program is to address the critical needs of the specialty crop industry by awarding grants to support research and extension that address key challenges of national, regional, and multi-state importance in sustaining all components of food and agriculture, including conventional and organic food production systems. Projects must address at least o...
Source: Grants.gov - Category: Research Tags: Agriculture Source Type: funding

Related Links:

Called Winship at Midtown, the nearly $500 million building will consolidate cancer services and improve a patient's experience.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Abstract Human papillomaviruses (HPV) are small, double-stranded DNA viruses that cause cervical cancer, the second most lethal cancer among women in the world. Currently, two vaccines are on the market for preventing HPV-caused cervical cancers and warts. Both are virus-like particle (VLP)-based vaccines. However, these vaccines have limitations; they are costly, have an invasive route of administration, require trained personnel to administer, need cold chain storage to preserve them, and most of all, they are preventive vaccines that do not have curative effects. Therefore, it is necessary to develop therapeuti...
Source: J Pharm Pharm Sci - Category: Drugs & Pharmacology Authors: Tags: J Pharm Pharm Sci Source Type: research
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: CME Article Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: CME Article Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Perspective Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Trends and Innovations Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Snapshot Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Best of the Rest Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: CME Quiz Source Type: news
No abstract available
Source: Lippincott's Bone and Joint Newsletter - Category: Orthopaedics Tags: Bone and Joint in Brief Source Type: news
More News: Colleges | Funding | Genetics | Grants | Marketing | Research | Universities